These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5006447)

  • 1. The effect of antibiotics on Mycoplasma pneumoniae in vitro and in vivo.
    Slotkin RI; Clyde WA; Denny FW
    Am J Epidemiol; 1967 Jul; 86(1):225-37. PubMed ID: 5006447
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of antibiotic treatment for Mycoplasma pneumoniae infections.
    McCracken GH
    Pediatr Infect Dis; 1986; 5(1):167-71. PubMed ID: 3080736
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimicrobial effects of erythromycin microspheres against Mycoplasma Pneumoniae in rats].
    Li T; Wen J; Jiang WL; Gong M; Yang ZQ; Xiao H
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1875-7. PubMed ID: 18971193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
    Gohara Y; Arai S; Akashi A; Kuwano K; Tseng CC; Matsubara S; Matumoto M; Furudera T
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1826-30. PubMed ID: 8239590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of the in vitro and in vivo activity of ciprofloxacin against mycoplasmas.
    Furneri PM; Tempera G; Chiarenza A; Caccamo F; Speciale AM; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):346-9. PubMed ID: 3123079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of Mycoplasma pneumoniae to erythromycin: a clinical case with severe pulmonary, cerebral and systemic complications.
    Clara F; Von Busch C; Goeddertz P; Novotna I
    J Chemother; 1989 Jul; 1(4 Suppl):411-3. PubMed ID: 16312462
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of clarithromycin against Mycoplasma pneumoniae.
    Cassell GH; Drnec J; Waites KB; Pate MS; Duffy LB; Watson HL; McIntosh JC
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():47-59. PubMed ID: 1827102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976-2006: emergence of macrolide-resistant strains.
    Okazaki N; Ohya H; Sasaki T
    Jpn J Infect Dis; 2007 Sep; 60(5):325-6. PubMed ID: 17881881
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of oxytetracycline and erythromycin on Syrian hamsters after intratracheal infection with Mycoplasma pneumoniae.
    Ritter E; Lange A; Rockel C; Ortel J
    J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):83-9. PubMed ID: 3106470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
    Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental and clinical studies of sparfloxacin in Mycoplasma pneumoniae infection.
    Kaku M; Ishida K; Kohno S; Koga H; Hara K; Usui T
    Drugs; 1995; 49 Suppl 2():412-3. PubMed ID: 8549381
    [No Abstract]   [Full Text] [Related]  

  • 12. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
    Cao B; Qu JX; Yin YD; Eldere JV
    Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.
    Miyashita N; Maruyama T; Kobayashi T; Kobayashi H; Taguchi O; Kawai Y; Yamaguchi T; Ouchi K; Oka M
    J Infect Chemother; 2011 Feb; 17(1):114-8. PubMed ID: 20676912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
    Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
    Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic-resistant mutants of Mycoplasma pneumoniae.
    Stopler T; Gerichter CB; Branski D
    Isr J Med Sci; 1980 Mar; 16(3):169-73. PubMed ID: 6771227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo efficacies of T-3811ME (BMS-284756) against Mycoplasma pneumoniae.
    Takahata M; Shimakura M; Hori R; Kizawa K; Todo Y; Minami S; Watanabe Y; Narita H
    Antimicrob Agents Chemother; 2001 Jan; 45(1):312-5. PubMed ID: 11120986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.
    Waites KB; Crabb DM; Liu Y; Duffy LB
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7502-7504. PubMed ID: 27671057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fundamental studies of josamycin against Mycoplasma pneumoniae (author's transl)].
    Izumikawa K; Komori M; Tomita H; Sai M; Suyama N; Iwasaki H; Fukui M; Hara K
    Jpn J Antibiot; 1981 Sep; 34(9):1288-91. PubMed ID: 6799669
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.